Establishing and Eliminating Cue-drug Associations in Human Cocaine Addiction
NCT01978457 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2020-03-02
Summary
We will develop a procedure for conditioning cue-cocaine associations in human drug users. Next, we will reactivate that learning and intervene pharmacologically to prevent the reconsolidation of cue-drug memories. We hypothesize that a combined behavioral and pharmacological approach will have significant potential for persistently inhibiting relapse.
Conditions
- Cocaine Dependent Subjects
Interventions
- DRUG
-
cocaine hydrochloride
- DRUG
-
propranolol
- DRUG
Sponsors & Collaborators
-
Yale University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- QUADRUPLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Sequenced Behavioral and Medication Intervention for Cocaine Dependence
NCT01986075 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving
NCT01822587 ·Status: COMPLETED ·Phase: PHASE2
-
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
NCT00015275 ·Status: COMPLETED ·Phase: PHASE4
-
Neurocognitive Factors in Substance Use Treatment Response: The Ways of Rewarding Abstinence Project
NCT03799341 ·Status: COMPLETED ·Phase: NA
-
Propranolol for Treatment of Cocaine Addiction - 2
NCT00000197 ·Status: COMPLETED ·Phase: PHASE2
-
Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence
NCT01468012 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1
NCT00094315 ·Status: UNKNOWN ·Phase: PHASE1
-
Sex Differences in Progesterone Effects on Responses to Stress and Drug Cues
NCT00585520 ·Status: COMPLETED ·Phase: PHASE1
-
Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study
NCT04721418 ·Status: RECRUITING
-
Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder
NCT02537873 ·Status: COMPLETED ·Phase: PHASE1
-
Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET
NCT02152670 ·Status: TERMINATED ·Phase: NA
-
PET Assays of Striatal Dopamine Marker in Cocaine Craving
NCT01036516 ·Status: COMPLETED
-
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
NCT00000276 ·Status: TERMINATED ·Phase: PHASE1
-
Developing Computer Based Treatments for Addiction
NCT00586534 ·Status: COMPLETED ·Phase: NA
-
Beta-blockade Effects on Memory for Cocaine Craving
NCT00830362 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Propranolol on Responses to Drug-Related Imagery Scripts
NCT00688805 ·Status: TERMINATED ·Phase: PHASE1
-
Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)
NCT01437293 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence
NCT01984177 ·Status: COMPLETED
-
Extending Long-term Outcomes Through an Adaptive Aftercare Intervention
NCT02143063 ·Status: COMPLETED ·Phase: NA
-
D-Cycloserine Facilitation of Cocaine - Cue Extinction
NCT00759473 ·Status: COMPLETED ·Phase: PHASE2
-
Medications for Stopping Cocaine Dependence and Preventing Relapse
NCT00218023 ·Status: COMPLETED ·Phase: PHASE2
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
NCT00040066 ·Status: UNKNOWN ·Phase: PHASE1
-
Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2
NCT00000316 ·Status: COMPLETED ·Phase: PHASE1
-
Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1
NCT00000315 ·Status: COMPLETED ·Phase: PHASE1
-
Piracetam for Treatment of Cocaine Addiction, Phase II - 4
NCT00000199 ·Status: WITHDRAWN ·Phase: PHASE1